Managing Anticoagulation for COVID-19-Related Lung Transplantation
J Cardiothorac Vasc Anesth
.
2023 Feb;37(2):334-335.
doi: 10.1053/j.jvca.2022.10.022.
Epub 2022 Oct 29.
Authors
W Everett Fox
1
,
Janki Patel
2
,
Matthew W Cross
2
,
John S McNeil
2
,
Jacob Raphael
3
,
Randal S Blank
2
Affiliations
1
Department of Anesthesiology, University of Virginia, Charlottesville, VA. Electronic address: EFOX629@gmail.com.
2
Department of Anesthesiology, University of Virginia, Charlottesville, VA.
3
Department of Anesthesiology, Thomas Jefferson University Hospitals, Philadelphia, PA.
PMID:
36414531
PMCID:
PMC9617652
DOI:
10.1053/j.jvca.2022.10.022
No abstract available
Publication types
Letter
MeSH terms
Anticoagulants / pharmacology
Anticoagulants / therapeutic use
Blood Coagulation
COVID-19*
Humans
Lung Transplantation* / adverse effects
SARS-CoV-2
Substances
Anticoagulants